Author:
Shen Xue,Zhang Zhongwen,Zhang Xiaoqian,Zhao Junyu,Zhou Xiaojun,Xu Qinglei,Shang Hongxia,Dong Jianjun,Liao Lin
Funder
National Natural Science Foundation of China
Natural Science Foundation of Shandong (CN)
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism
Reference38 articles.
1. Shi Y, Hu FB. The global implications of diabetes and cancer. Lancet. 2014;383(9933):1947–8.
2. Guo Z, Liu X, et al. Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC-MS/MS and iTRAQ quantification. J Transl Med. 2015;13(1):371.
3. Toneli M, Moye L, Sacks FM, Cole T, Curhan GC. Effect of pravastatin on loss of renal fuction in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol. 2003;14:1605–13.
4. Guijaro C, Keane WF. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutary coenzyme A reductase inhibitors in the prevention of glomerulosclerosis. Miner Electrolyte Metab. 1996;22(1–3):147–52.
5. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int. 2001;59:260–9.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献